AAPL343.58-4.14 (-1.19%) ▼|ABBV285.94+0.30 (+0.11%) ▲|ABT103.73+0.03 (+0.03%) ▲|ACN243.84-5.53 (-2.22%) ▼|ADBE254.51-9.31 (-3.53%) ▼|AMAT391.89+14.65 (+3.88%) ▲|AMD533.06+16.27 (+3.15%) ▲|AMGN441.29+2.03 (+0.46%) ▲|AMT189.23+0.26 (+0.14%) ▲|AMZN249.00+1.00 (+0.40%) ▲|AVGO331.01+9.33 (+2.90%) ▲|AXP313.88+0.66 (+0.21%) ▲|BA188.99+0.64 (+0.34%) ▲|BAC50.74+0.18 (+0.36%) ▲|BKNG151.78-4.05 (-2.60%) ▼|BLK1,131.27+13.02 (+1.16%) ▲|BMY61.31-0.17 (-0.28%) ▼|BNY147.57+2.93 (+2.03%) ▲|BRK-B545.93+3.74 (+0.69%) ▲|C121.64+1.02 (+0.85%) ▲|CAT695.62+10.25 (+1.50%) ▲|CL92.58-1.47 (-1.56%) ▼|CMCSA21.95-0.75 (-3.28%) ▼|COF202.91+1.57 (+0.78%) ▲|COP151.54+0.74 (+0.49%) ▲|COST1,000.76-2.56 (-0.26%) ▼|CRM244.61-3.96 (-1.59%) ▼|CSCO110.53+4.03 (+3.78%) ▲|CVS92.17-1.31 (-1.40%) ▼|CVX232.52-0.70 (-0.30%) ▼|DE639.90-6.26 (-0.97%) ▼|DHR231.88+1.38 (+0.60%) ▲|DIS110.22-2.30 (-2.04%) ▼|DUK124.33-0.65 (-0.52%) ▼|EMR162.18+0.59 (+0.36%) ▲|FDX301.02+2.30 (+0.77%) ▲|GD354.67+5.31 (+1.52%) ▲|GE286.40+0.76 (+0.27%) ▲|GEV857.99+42.99 (+5.27%) ▲|GILD158.38+2.34 (+1.50%) ▲|GM76.24+0.32 (+0.42%) ▲|GOOG314.78-2.50 (-0.79%) ▼|GOOGL317.99-2.22 (-0.69%) ▼|GS897.99+22.31 (+2.55%) ▲|HD316.90-2.93 (-0.92%) ▼|HON219.75-1.40 (-0.63%) ▼|IBM252.76-0.80 (-0.32%) ▼|INTC91.85+4.89 (+5.62%) ▲|INTU335.36-8.04 (-2.34%) ▼|ISRG448.02-4.27 (-0.94%) ▼|JNJ265.55+1.74 (+0.66%) ▲|JPM334.93+3.35 (+1.01%) ▲|KO92.57-0.14 (-0.15%) ▼|LIN510.18+1.35 (+0.27%) ▲|LLY1,280.34+6.88 (+0.54%) ▲|LMT631.11+26.93 (+4.46%) ▲|LOW196.94-1.74 (-0.88%) ▼|LRCX239.61+9.51 (+4.13%) ▲|MA614.10-9.51 (-1.52%) ▼|MCD249.22+0.76 (+0.31%) ▲|MDLZ62.71-1.10 (-1.72%) ▼|MDT94.30-1.11 (-1.16%) ▼|META635.86-6.76 (-1.05%) ▼|MMM172.44-1.02 (-0.59%) ▼|MO73.56-0.76 (-1.02%) ▼|MRK140.96-4.32 (-2.97%) ▼|MS185.38+5.89 (+3.28%) ▲|MSFT531.29+6.78 (+1.29%) ▲|MU914.17+36.62 (+4.17%) ▲|NEE82.14+0.04 (+0.04%) ▲|NFLX63.11-2.74 (-4.16%) ▼|NKE37.61+0.31 (+0.82%) ▲|NOW156.43-2.53 (-1.59%) ▼|NVDA216.26+5.30 (+2.51%) ▲|ORCL125.99-0.17 (-0.13%) ▼|PEP135.20-0.57 (-0.42%) ▼|PFE29.78-0.25 (-0.83%) ▼|PG159.00-2.02 (-1.25%) ▼|PLTR199.36+2.61 (+1.32%) ▲|PM201.78+2.31 (+1.16%) ▲|QCOM178.50+2.59 (+1.47%) ▲|RTX197.18+6.17 (+3.23%) ▲|SBUX102.05+1.25 (+1.24%) ▲|SCHW89.81-0.78 (-0.86%) ▼|SO92.36-0.53 (-0.57%) ▼|SPG212.39+0.76 (+0.36%) ▲|T20.74-0.19 (-0.91%) ▼|TMO680.03+6.21 (+0.92%) ▲|TMUS145.09-1.46 (-0.99%) ▼|TSLA395.16+22.94 (+6.16%) ▲|TXN296.43+11.74 (+4.12%) ▲|UBER65.95-0.76 (-1.13%) ▼|UNH410.05-8.04 (-1.92%) ▼|UNP295.11+2.24 (+0.76%) ▲|UPS100.14-0.92 (-0.91%) ▼|USB59.87+0.29 (+0.49%) ▲|V404.10-3.82 (-0.94%) ▼|VZ43.09-1.57 (-3.51%) ▼|WFC82.75+0.36 (+0.44%) ▲|WMT119.68-0.21 (-0.18%) ▼|XOM184.35+1.14 (+0.62%) ▲|AAPL343.58-4.14 (-1.19%) ▼|ABBV285.94+0.30 (+0.11%) ▲|ABT103.73+0.03 (+0.03%) ▲|ACN243.84-5.53 (-2.22%) ▼|ADBE254.51-9.31 (-3.53%) ▼|AMAT391.89+14.65 (+3.88%) ▲|AMD533.06+16.27 (+3.15%) ▲|AMGN441.29+2.03 (+0.46%) ▲|AMT189.23+0.26 (+0.14%) ▲|AMZN249.00+1.00 (+0.40%) ▲|AVGO331.01+9.33 (+2.90%) ▲|AXP313.88+0.66 (+0.21%) ▲|BA188.99+0.64 (+0.34%) ▲|BAC50.74+0.18 (+0.36%) ▲|BKNG151.78-4.05 (-2.60%) ▼|BLK1,131.27+13.02 (+1.16%) ▲|BMY61.31-0.17 (-0.28%) ▼|BNY147.57+2.93 (+2.03%) ▲|BRK-B545.93+3.74 (+0.69%) ▲|C121.64+1.02 (+0.85%) ▲|CAT695.62+10.25 (+1.50%) ▲|CL92.58-1.47 (-1.56%) ▼|CMCSA21.95-0.75 (-3.28%) ▼|COF202.91+1.57 (+0.78%) ▲|COP151.54+0.74 (+0.49%) ▲|COST1,000.76-2.56 (-0.26%) ▼|CRM244.61-3.96 (-1.59%) ▼|CSCO110.53+4.03 (+3.78%) ▲|CVS92.17-1.31 (-1.40%) ▼|CVX232.52-0.70 (-0.30%) ▼|DE639.90-6.26 (-0.97%) ▼|DHR231.88+1.38 (+0.60%) ▲|DIS110.22-2.30 (-2.04%) ▼|DUK124.33-0.65 (-0.52%) ▼|EMR162.18+0.59 (+0.36%) ▲|FDX301.02+2.30 (+0.77%) ▲|GD354.67+5.31 (+1.52%) ▲|GE286.40+0.76 (+0.27%) ▲|GEV857.99+42.99 (+5.27%) ▲|GILD158.38+2.34 (+1.50%) ▲|GM76.24+0.32 (+0.42%) ▲|GOOG314.78-2.50 (-0.79%) ▼|GOOGL317.99-2.22 (-0.69%) ▼|GS897.99+22.31 (+2.55%) ▲|HD316.90-2.93 (-0.92%) ▼|HON219.75-1.40 (-0.63%) ▼|IBM252.76-0.80 (-0.32%) ▼|INTC91.85+4.89 (+5.62%) ▲|INTU335.36-8.04 (-2.34%) ▼|ISRG448.02-4.27 (-0.94%) ▼|JNJ265.55+1.74 (+0.66%) ▲|JPM334.93+3.35 (+1.01%) ▲|KO92.57-0.14 (-0.15%) ▼|LIN510.18+1.35 (+0.27%) ▲|LLY1,280.34+6.88 (+0.54%) ▲|LMT631.11+26.93 (+4.46%) ▲|LOW196.94-1.74 (-0.88%) ▼|LRCX239.61+9.51 (+4.13%) ▲|MA614.10-9.51 (-1.52%) ▼|MCD249.22+0.76 (+0.31%) ▲|MDLZ62.71-1.10 (-1.72%) ▼|MDT94.30-1.11 (-1.16%) ▼|META635.86-6.76 (-1.05%) ▼|MMM172.44-1.02 (-0.59%) ▼|MO73.56-0.76 (-1.02%) ▼|MRK140.96-4.32 (-2.97%) ▼|MS185.38+5.89 (+3.28%) ▲|MSFT531.29+6.78 (+1.29%) ▲|MU914.17+36.62 (+4.17%) ▲|NEE82.14+0.04 (+0.04%) ▲|NFLX63.11-2.74 (-4.16%) ▼|NKE37.61+0.31 (+0.82%) ▲|NOW156.43-2.53 (-1.59%) ▼|NVDA216.26+5.30 (+2.51%) ▲|ORCL125.99-0.17 (-0.13%) ▼|PEP135.20-0.57 (-0.42%) ▼|PFE29.78-0.25 (-0.83%) ▼|PG159.00-2.02 (-1.25%) ▼|PLTR199.36+2.61 (+1.32%) ▲|PM201.78+2.31 (+1.16%) ▲|QCOM178.50+2.59 (+1.47%) ▲|RTX197.18+6.17 (+3.23%) ▲|SBUX102.05+1.25 (+1.24%) ▲|SCHW89.81-0.78 (-0.86%) ▼|SO92.36-0.53 (-0.57%) ▼|SPG212.39+0.76 (+0.36%) ▲|T20.74-0.19 (-0.91%) ▼|TMO680.03+6.21 (+0.92%) ▲|TMUS145.09-1.46 (-0.99%) ▼|TSLA395.16+22.94 (+6.16%) ▲|TXN296.43+11.74 (+4.12%) ▲|UBER65.95-0.76 (-1.13%) ▼|UNH410.05-8.04 (-1.92%) ▼|UNP295.11+2.24 (+0.76%) ▲|UPS100.14-0.92 (-0.91%) ▼|USB59.87+0.29 (+0.49%) ▲|V404.10-3.82 (-0.94%) ▼|VZ43.09-1.57 (-3.51%) ▼|WFC82.75+0.36 (+0.44%) ▲|WMT119.68-0.21 (-0.18%) ▼|XOM184.35+1.14 (+0.62%) ▲|
16.7 C
New York
Monday, October 26, 2026

Tag: action

newsFORsourcecompanycontentinformation1releasesmarket

Sterotherapeutics Announces First Patient Dosed in Phase 2 Clinical Trial Evaluating ST-002 for Cushing’s Syndrome

DOYLESTOWN, Pa., June 24, 2025 /PRNewswire/ -- Sterotherapeutics LLC, a clinical-stage biopharmaceutical company focused on rare endocrine diseases, today announced that the first patient...

Stabilization Notice – Pre- stab – Webuild

24 th June 2025

York revealed as UK’s friendliest city, as Aviva research finds the nation’s community spirit is strong – but millions are without access to pubs...

Survey of over 6,000 people finds the UK is more trusting, friendly and community-minded than some may thinkThree quarters of people trust their neighbours (73%)...

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...

Monster Energy’s BMX, Moto X, and Skateboard Athletes Claim Gold Medals and Make Action Sports History at X Games Osaka 2025

Monster Energy Team Claims 13 Medals (4 Gold, 4 Silver, 5 Bronze) at X Games Osaka 15-Year-Old Arisa Trew from Australia, Claims Double Gold in Women's...

Media Matters Initiates Legal Action Against FTC: Analyzing Advertising Investigation Impact

Media Matters, a liberal advocacy organization, has initiated legal proceedings against the Federal Trade Commission (FTC), asserting that the agency's investigation into potential collusion...

Call for Submissions: Peace Palace awards 2025 Youth Carnegie Peace Prize

THE HAGUE, Netherlands, June 24, 2025 /PRNewswire/ -- Across the globe, young people are emerging as powerful agents of peace, driving change in their...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Open Lending Corporation, Civitas Resources, and Avis Budget and...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Open Lending Corporation (NASDAQ:LPRO), Civitas Resources, Inc. (NYSE: CIVI), and Avis Budget Group, Inc. (NASDAQ:CAR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UnitedHealth, Bitfarms, and Reddit and Encourages Investors to Contact...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UnitedHealth Group Incorporated (NYSE: UNH), Bitfarms Ltd. (NASDAQ: BITF), and Reddit, Inc. (NYSE:RDDT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Krispy Kreme, Inc. (NASDAQ:DNUT), Strategy Incorporated (NASDAQ:MSTR), Organon & Co. (NYSE:OGN), and Iovance Biotherapeutics, Inc. (NASDAQ:IOVA). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Reckitt Benckiser Group plc (OTC:RBGLY), UroGen Pharma Ltd. (NASDAQ:URGN), Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, and Tempus and Encourages Investors to Contact...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Vestis Corporation (NYSE:VSTS), PepGen, Inc. (NASDAQ: PEPG), and Tempus AI, Inc. (NASDAQ: TEM). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Fortrea Holdings Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Pending Against FTRE

Robbins LLP is Investigating Allegations that Fortrea Holdings, Inc. (FTRE) Misled Investors Regarding the Progress of its Pre-Spin Projects

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAction

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers